Compare ALEMBIC LTD with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ALEMBIC PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ALEMBIC PHARMA ALEMBIC LTD/
ALEMBIC PHARMA
 
P/E (TTM) x 53.0 24.6 215.0% View Chart
P/BV x 4.6 7.3 62.6% View Chart
Dividend Yield % 0.2 0.5 42.7%  

Financials

 ALEMBIC LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ALEMBIC PHARMA
Mar-19
ALEMBIC LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs72664 10.8%   
Low Rs34412 8.2%   
Sales per share (Unadj.) Rs4.7208.7 2.3%  
Earnings per share (Unadj.) Rs6.131.0 19.7%  
Cash flow per share (Unadj.) Rs6.237.1 16.8%  
Dividends per share (Unadj.) Rs0.205.50 3.6%  
Dividend yield (eoy) %0.41.0 37.0%  
Book value per share (Unadj.) Rs40.7144.2 28.2%  
Shares outstanding (eoy) m267.03188.52 141.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.6 436.8%   
Avg P/E ratio x8.717.4 50.0%  
P/CF ratio (eoy) x8.514.5 58.5%  
Price / Book Value ratio x1.33.7 34.9%  
Dividend payout %3.317.7 18.5%   
Avg Mkt Cap Rs m14,139101,461 13.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2077,467 2.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25539,347 3.2%  
Other income Rs m37094 394.7%   
Total revenues Rs m1,62539,441 4.1%   
Gross profit Rs m1118,736 1.3%  
Depreciation Rs m381,152 3.3%   
Interest Rs m2184 0.9%   
Profit before tax Rs m4427,493 5.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1,212-93 -1,306.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,568 1.5%   
Profit after tax Rs m1,6305,844 27.9%  
Gross profit margin %8.922.2 39.9%  
Effective tax rate %5.420.9 25.9%   
Net profit margin %129.814.9 874.3%  
BALANCE SHEET DATA
Current assets Rs m1,86719,577 9.5%   
Current liabilities Rs m59114,896 4.0%   
Net working cap to sales %101.611.9 854.4%  
Current ratio x3.21.3 240.3%  
Inventory Days Days9490 105.0%  
Debtors Days Days7445 162.2%  
Net fixed assets Rs m1,79127,097 6.6%   
Share capital Rs m534377 141.7%   
"Free" reserves Rs m10,32426,811 38.5%   
Net worth Rs m10,85827,188 39.9%   
Long term debt Rs m414,993 0.8%   
Total assets Rs m11,59147,778 24.3%  
Interest coverage x260.941.7 625.6%   
Debt to equity ratio x00.2 2.1%  
Sales to assets ratio x0.10.8 13.1%   
Return on assets %14.112.6 111.6%  
Return on equity %15.021.5 69.8%  
Return on capital %15.223.6 64.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1919,453 0.1%   
Fx outflow Rs m2646,065 4.4%   
Net fx Rs m-24413,388 -1.8%   
CASH FLOW
From Operations Rs m2368,120 2.9%  
From Investments Rs m-224-7,556 3.0%  
From Financial Activity Rs m-27590 -4.5%  
Net Cashflow Rs m-151,153 -1.3%  

Share Holding

Indian Promoters % 64.0 74.1 86.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.9 6.9%  
FIIs % 9.7 9.1 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 13.9 187.8%  
Shareholders   54,701 49,328 110.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 7, 2020 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS